Liquid Biopsy Market Projected to Grow at a Steady Pace During 2022-2028
The liquid biopsy market was estimated at USD 2.4 billion in 2021 and is expected to grow at a CAGR of 18% during 2022-2028 to reach USD 7.64 billion in 2028.
Liquid biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue, mainly blood. This technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive.
Read More: https://www.stratviewresearch.....com/3302/liquid-biop
Like
Comment
Share
